Fontan Procedure
13
2
3
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.4%
2 terminated out of 13 trials
77.8%
-8.7% vs benchmark
8%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation
The iPeer2Peer Mentorship Program for Young Adults With Heart Disease
Pulmonary Determinants of Cardiorespiratory Fitness in Fontan Patients
Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Clinical Outcomes in Fenestrated Extra-Cardiac Fontan in Low Preoperative Risk Profiles
Cholate Clearance in Fontans
Exercise Capacity in Patients With Fontan Procedure
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study